KARYOPHARM THERAPEUTICS INC's ticker is KPTI and the CUSIP is 48576U106. A total of 146 filers reported holding KARYOPHARM THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 3.32 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,493 | +31.4% | 2,060 | +94.3% | 0.00% | – |
| Q2 2023 | $1,897 | -55.0% | 1,060 | 0.0% | 0.00% | – |
| Q1 2023 | $4,219 | +22.5% | 1,060 | 0.0% | 0.00% | – |
| Q4 2022 | $3,445 | -43.3% | 1,060 | 0.0% | 0.00% | – |
| Q3 2022 | $6,074 | +21.4% | 1,060 | 0.0% | 0.00% | – |
| Q2 2022 | $5,003 | -41.4% | 1,060 | 0.0% | 0.00% | – |
| Q1 2022 | $8,544 | +9.5% | 1,060 | 0.0% | 0.00% | – |
| Q4 2021 | $7,802 | – | 1,060 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Delphi Management Partners VIII, L.L.C. | 2,263,006 | $13,170,000 | 9.51% |
| Palo Alto Investors LP | 5,383,052 | $31,329,000 | 1.89% |
| Birchview Capital, LP | 246,000 | $1,432,000 | 0.97% |
| Rubric Capital Management LP | 3,375,758 | $19,647,000 | 0.55% |
| Lombard Odier Asset Management (Switzerland) SA | 1,517,804 | $8,834,000 | 0.55% |
| RICE HALL JAMES & ASSOCIATES, LLC | 1,401,861 | $8,159,000 | 0.30% |
| AlphaCentric Advisors LLC | 136,000 | $792,000 | 0.20% |
| Bridgefront Capital, LLC | 20,946 | $122,000 | 0.13% |
| Hennion & Walsh Asset Management, Inc. | 407,474 | $2,371,000 | 0.12% |
| Virtus ETF Advisers LLC | 44,364 | $258,000 | 0.11% |